Literature DB >> 4412460

Clindamycin-associated colitis. A prospective study.

F J Tedesco, R W Barton, D H Alpers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4412460     DOI: 10.7326/0003-4819-81-4-429

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  114 in total

1.  Antibiotic-induced diarrhoea.

Authors:  E R Smith; S J Goulston
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Letter: Clindamycin-associated pseudomembranous colitis.

Authors:  B R Miller; M H Wheeler
Journal:  Br Med J       Date:  1975-08-16

3.  Letter: Postoperative pseudomembranous colitis.

Authors:  A R Crapp; J Powis; C Clark; M R Keighley; J Alexander-Williams
Journal:  Br Med J       Date:  1975-07-26

4.  Incidence and significance of intraperitoneal anaerobic bacteria.

Authors:  H H Stone; L D Kolb; C E Geheber
Journal:  Ann Surg       Date:  1975-05       Impact factor: 12.969

Review 5.  Clindamycin as an antimalarial drug: review of clinical trials.

Authors:  Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

7.  Drug risk factors associated with a sustained outbreak of Clostridium difficile diarrhea in a teaching hospital.

Authors:  S K Nath; S Salama; D Persaud; J H Thornley; I Smith; G Foster; C Rotstein
Journal:  Can J Infect Dis       Date:  1994-11

Review 8.  Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance.

Authors:  Robert A Britton; Vincent B Young
Journal:  Trends Microbiol       Date:  2012-05-15       Impact factor: 17.079

9.  Editorial: Antibiotic diarrhoea.

Authors: 
Journal:  Br Med J       Date:  1975-11-01

10.  Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.

Authors:  D L Vesely; K D Straub; C M Nolan; R D Rolfe; S M Finegold; T P Monson
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.